These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1732 related articles for article (PubMed ID: 29936690)

  • 1. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota.
    Leblhuber F; Ehrlich D; Steiner K; Geisler S; Fuchs D; Lanser L; Kurz K
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33504065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
    Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
    mBio; 2019 May; 10(3):. PubMed ID: 31064831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation.
    Garcez ML; Jacobs KR; Guillemin GJ
    Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
    Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and pro/prebiotics in Alzheimer's disease.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Aging (Albany NY); 2020 Mar; 12(6):5539-5550. PubMed ID: 32191919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
    Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
    J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of gutmicrobiota in cognition, behaviour and Alzheimer's disease.
    de J R De-Paula V; Forlenza AS; Forlenza OV
    Pharmacol Res; 2018 Oct; 136():29-34. PubMed ID: 30138667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.
    Giau VV; Wu SY; Jamerlan A; An SSA; Kim SY; Hulme J
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30441866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.
    Das TK; Ganesh BP
    Gut Microbes; 2023; 15(1):2206504. PubMed ID: 37127846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gut microbiota in pathogenesis of Alzheimer's disease.
    Bostanciklioğlu M
    J Appl Microbiol; 2019 Oct; 127(4):954-967. PubMed ID: 30920075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.